GB9601042D0 - Medical use - Google Patents

Medical use

Info

Publication number
GB9601042D0
GB9601042D0 GBGB9601042.6A GB9601042A GB9601042D0 GB 9601042 D0 GB9601042 D0 GB 9601042D0 GB 9601042 A GB9601042 A GB 9601042A GB 9601042 D0 GB9601042 D0 GB 9601042D0
Authority
GB
United Kingdom
Prior art keywords
medical use
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9601042.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9601042.6A priority Critical patent/GB9601042D0/en
Publication of GB9601042D0 publication Critical patent/GB9601042D0/en
Priority to JP9525694A priority patent/JP2000503313A/en
Priority to PCT/EP1997/000197 priority patent/WO1997025981A1/en
Priority to EP97901056A priority patent/EP0909169A1/en
Priority to US10/038,331 priority patent/US20020082200A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB9601042.6A 1994-07-13 1996-01-17 Medical use Pending GB9601042D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9601042.6A GB9601042D0 (en) 1996-01-17 1996-01-17 Medical use
JP9525694A JP2000503313A (en) 1996-01-17 1997-01-14 Pharmaceutical use
PCT/EP1997/000197 WO1997025981A1 (en) 1996-01-17 1997-01-14 Medical use
EP97901056A EP0909169A1 (en) 1996-01-17 1997-01-14 Medical use
US10/038,331 US20020082200A1 (en) 1994-07-13 2002-01-03 Use of inhibitors of human S-CD23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9601042.6A GB9601042D0 (en) 1996-01-17 1996-01-17 Medical use

Publications (1)

Publication Number Publication Date
GB9601042D0 true GB9601042D0 (en) 1996-03-20

Family

ID=10787227

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9601042.6A Pending GB9601042D0 (en) 1994-07-13 1996-01-17 Medical use

Country Status (4)

Country Link
EP (1) EP0909169A1 (en)
JP (1) JP2000503313A (en)
GB (1) GB9601042D0 (en)
WO (1) WO1997025981A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929527D0 (en) * 1999-12-14 2000-02-09 Smithkline Beecham Plc Novel compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827308D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
WO1990011287A1 (en) * 1989-03-21 1990-10-04 The United States Of America, Represented By The Secretary, United States Department Of Commerce Matrix metalloproteinase inhibitor peptides
GB9001625D0 (en) * 1990-01-24 1990-03-21 Ciba Geigy Ag A pharmaceutical preparation for maturation of prothymocytes
AU655943B2 (en) * 1990-09-21 1995-01-19 Salk Institute For Biological Studies, The Functional antagonism between proto-oncoprotein c-jun and hormone receptors
WO1992016517A1 (en) * 1991-03-22 1992-10-01 Xenova Limited Pharmaceutical xanthone derivatives
KR930002833A (en) * 1991-07-08 1993-02-23 강석재 Device for checking break of electric circuit
WO1993018173A2 (en) * 1992-03-11 1993-09-16 Xenova Limited Cd4 binding agents and inhibitors of collagenase and protein kinase c
EP0634998B1 (en) * 1992-04-07 1997-03-19 British Biotech Pharmaceuticals Limited Hydroxamic acid based collagenase and cytokine inhibitors
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
NZ262447A (en) * 1993-03-16 1996-07-26 British Biotech Pharm Hydroxamic acid derivatives and their use as pharmaceutical agents
GB9307956D0 (en) * 1993-04-17 1993-06-02 Walls Alan J Hydroxamic acid derivatives
US5455262A (en) * 1993-10-06 1995-10-03 Florida State University Mercaptosulfide metalloproteinase inhibitors
GB9320660D0 (en) * 1993-10-07 1993-11-24 British Bio Technology Inhibition of cytokine production
UA48121C2 (en) * 1993-11-04 2002-08-15 Сінтекс (С.Ш.А.) Інк. Inhibitors of matrix metalloproteases and pharmaceutical composition on their basis
GB9323165D0 (en) * 1993-11-10 1994-01-05 Chiros Ltd Compounds
JPH07196598A (en) * 1993-12-28 1995-08-01 Kuraray Co Ltd Hydroxamic acid derivative and medicine composition containing the same as active ingredient
PL179997B1 (en) * 1994-01-20 2000-11-30 British Biotech Pharm Inhibitors of metalloproteinases
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
CA2181709A1 (en) * 1994-01-22 1995-07-27 Raymond Paul Beckett Hydroxamic acid derivatives as metalloproteinase inhibitors
US5514716A (en) * 1994-02-25 1996-05-07 Sterling Winthrop, Inc. Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
GB9404046D0 (en) * 1994-03-03 1994-04-20 Smithkline Beecham Corp Novel compounds
GB9501737D0 (en) * 1994-04-25 1995-03-22 Hoffmann La Roche Hydroxamic acid derivatives
AU2361295A (en) * 1994-04-28 1995-11-29 Merck & Co., Inc. N-carboxyalkyl derivatives as antidegenerative active agents
AU2394795A (en) * 1994-04-28 1995-11-29 Du Pont Merck Pharmaceutical Company, The Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use

Also Published As

Publication number Publication date
EP0909169A1 (en) 1999-04-21
JP2000503313A (en) 2000-03-21
WO1997025981A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
GB9617502D0 (en) Medical devices
PL328822A1 (en) Human bikinine
IL128850A0 (en) Medical treatment
IL127735A0 (en) Medical device
GB9617034D0 (en) Medical cryo-surgical device
GB9802599D0 (en) Medical use
GB9610682D0 (en) Medical devices
AU130614S (en) Tissue
GB9414157D0 (en) Medical use
GB9620777D0 (en) Therapeutic use
GB9621990D0 (en) Use
EP0797592A4 (en) Human stanniocalcin-alpha
GB9617550D0 (en) Medical ice-pack
GB9601042D0 (en) Medical use
GB9615924D0 (en) Medical device
GB9611192D0 (en) Use
ZA947865B (en) Human glactokinase
GB9606686D0 (en) Medical use
GB9626920D0 (en) Medical use
EP0795006A4 (en) HUMAN MutT2
GB9603437D0 (en) Medical aid
GB2331847B (en) Medical cryo-surgical device
GB9617982D0 (en) Medical devices
GB9622571D0 (en) Medical devices
GB9618463D0 (en) Medical devices